$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
培米替尼在哪买的到?
2025-10-19 11:44:20
Check Details
胆管癌治疗药物培米替尼说明书
2025-10-19 11:44:20
Check Details
培米替尼是靶向药吗?
2025-10-19 11:44:20
Check Details
培米替尼是什么药?
2025-10-19 11:44:20
Check Details
日本批准的培米替尼用于不可切除性FGFR+胆道癌
2025-10-19 11:44:20
Check Details
FDA授予了futibatinib治疗胆管癌的突破性治疗资格认定
2025-10-19 11:44:20
Check Details
FDA授予艾伏尼布优先审评资格用于IDH1突变型胆管癌
2025-10-19 11:44:20
Check Details
【重磅】胆管癌首款靶向治疗药物-培美替尼
2025-10-19 11:44:20
Check Details
培美替尼在国内买的到吗?多少钱一盒?纳入医保了吗?
2025-10-19 11:44:20
Check Details
【热点】培美替尼使胆管癌患者有了靶向疗法
2025-10-19 11:44:20
Check Details
靶向药培美替尼的问世是肝内胆管癌患者的福音
2025-10-19 11:44:20
Check Details
【关注度高】靶向药培美替尼改变了肝内胆管癌的治疗现状
2025-10-19 11:44:20
Check Details
1
2
...
23
24
25
26
27
28
29
...
4154
4155
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Sotorasib (Lumakras®): The First KRAS Inhibitor Revolutionizing Non-Small Cell Lung Cancer Treatment
2
LONSURF® (Trifluridine/Tipiracil): Unveiling the Global R&D and Supply Chain Behind the Oral Chemotherapy
3
FDA Approves Lilly's Inluriyo (Imlunestrant) for ESR1-Mutant Advanced Breast Cancer
4
Tivozanib: The Evolution of Highly Selective VEGFR Inhibition in Renal Cell Carcinoma
5
Trifluridine/Tipiracil: Managing Side Effects in Metastatic Colorectal and Gastric Cancer
6
Adagrasib Medication Management Guide for Special Populations
7
Olutasidenib (Rezlidhia): A Targeted Drug for IDH1-Mutated Relapsed/Refractory AML
8
Capmatinib Redefines Precision Therapy for MET-Mutated Lung Cancer
9
Cabozantinib: Pivotal Advancements and Global Implications in Multi-Cancer Treatment with Multi-Kinase Inhibition
10
Tucatinib (Tukysa): A Precision Medicine for HER2-Positive Breast & Colorectal Cancer
11
Global Breakthrough: Pralsetinib - Precision Medicine for RET Mutation-Driven Cancers
12
Elacestrant: Precision Therapy for ESR1-Mutant Resistant HR+/HER2- Advanced Breast Cancer